Clinical Trials Logo
  1. Home
  2. Hypercalciuria
  3. NCT01005082

Low Salt Diet in Idiopathic Hypercalciuria — LOSALT01  

Hypercalciuria Clinical Trial

Official title:
Calcium Nephrolithiasis: Clinical Characteristics and Nutritional Determinants

Clinical Trial Summary

Randomized clinical trial comparing water therapy plus low-salt diet to water therapy alone in patients affected by idiopathic calcium nephrolithiasis.

Treatment duration: three months Primary end-point: correction of hypercalciuria Main inclusion criteria: calcium stone formers with idiopathic hypercalciuria, with at least one stone expelled and analyzed by infrared spectrophotometry; presence of hypercalciuria (>300 mg/day in males and >200 mg/day in females); 18-65 years.

Main exclusion criteria: primary hyperparathyroidism, primary hyperoxaluria, enteric hyperoxaluria, bowel resection, inflammatory bowel disease, renal tubular acidosis, sarcoidosis, sponge kidney, hyperthyroidism, use of hypercalciuric drugs such as Vitamin D, acetazolamide, anti-epileptic drugs

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01005082
Study type Interventional
Source University of Parma
Contact
Status Completed
Phase Phase 2/Phase 3
Start date January 2005
Completion date December 2008
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT00169806 - Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis N/A
Terminated NCT03325114 - Safety and Efficacy of Chlorthalidone in Type 1 Diabetes Phase 2
Recruiting NCT03301038 - Rifampin in CYP24A1-related Hypercalcemia and Hypercalciuria Phase 2
Completed NCT00581828 - Does Treatment of Hypovitaminosis D Increase Calcium Absorption? Phase 4
Active, not recruiting NCT04495608 - Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels Phase 2
Suspended NCT03771105 - The Impact of Phosphate Metabolism on Healthy Aging Early Phase 1
Terminated NCT01928082 - The Effects of Estrogen Replacement Therapy in Postmenopausal Women With Hypercalciuria and Low Bone Mass Phase 2
Completed NCT02438267 - Preterm Infants and Nephrocalcinosis N/A
Completed NCT00004284 - Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria Phase 3
Completed NCT00765531 - Stone Disease in Children and Their Families